Enter Our 2021 Top 10 Innovations Contest
Enter Our 2021 Top 10 Innovations Contest
Submit your new product now to have a chance at being selected for a coveted spot in The Scientist’s 2021 competition.
Enter Our 2021 Top 10 Innovations Contest
Enter Our 2021 Top 10 Innovations Contest

Submit your new product now to have a chance at being selected for a coveted spot in The Scientist’s 2021 competition.

Submit your new product now to have a chance at being selected for a coveted spot in The Scientist’s 2021 competition.

drug development
Improving Ergonomics Reduces Contamination Risk in Microbiological QC Workflows
Improving Ergonomics Reduces Contamination Risk in Microbiological QC Workflows
The Scientist Creative Services Team in collaboration with Pall | Jun 16, 2021
Making filtration devices easier to clean reduces fatigue and injury risk while improving reproducibility.
Clinical Antibody Development: A Journey of Discovery
Clinical Antibody Development: A Journey of Discovery
Twist Bioscience | Jun 16, 2021
From identifying targets to testing lead candidates, developing antibodies into clinical therapies is a process full of twists and turns.
Inhaled Antibody Fragments Protect Infected Animals Against COVID-19
Inhaled Antibody Fragments Protect Infected Animals Against COVID-19
Roni Dengler, PhD | Jun 14, 2021
Tiny but powerful nanobodies may be the innovation that snuffs out the pandemic.
Taking the Stress Out of Weighing Powders
Taking the Stress Out of Weighing Powders
METTLER TOLEDO | Jun 11, 2021
Automated powder dispensing and dosing improve accuracy and reliability.
Updated
Biogen’s Alzheimer’s Drug Gets FDA Approval, Mixed Reviews
Biogen’s Alzheimer’s Drug Gets FDA Approval, Mixed Reviews
Kerry Grens | Jun 7, 2021
A lackluster performance in clinical trials of the monoclonal antibody aducanumab has left some experts unconvinced of its benefit.
SARS-CoV-2 Antigens Leaking from Gut to Blood Might Trigger MIS-C
SARS-CoV-2 Antigens Leaking from Gut to Blood Might Trigger MIS-C
Alejandra Manjarrez | Jun 3, 2021
Researchers find traces of SARS-CoV-2 in the stool and blood of kids with the post–COVID-19 inflammatory disorder, and signs of increased intestinal permeability.
Fecal Microbiota Transplantation is Poised for a Makeover
Fecal Microbiota Transplantation is Poised for a Makeover
Shawna Williams | Jun 1, 2021
With multiple microbiota therapeutics in the pipeline for recurrent Clostridium difficile infection, clinicians foresee a shift in treatment options for the condition.
Custom DNA Constructs Accelerate Therapeutic Research
Custom DNA Constructs Accelerate Therapeutic Research
Thermo Fisher Scientific | May 28, 2021
Gene synthesis and protein services bypass time-consuming steps and produce optimized results.
A Better Way to Detect Protein Aggregation
A Better Way to Detect Protein Aggregation
RedShift Bio | May 28, 2021
Early detection with microfluidic modulation spectroscopy (MMS) addresses protein instability and loss of function.
DEA Moves Toward Approving More Research Marijuana Growers
DEA Moves Toward Approving More Research Marijuana Growers
Shawna Williams | May 19, 2021
A regulatory change initiated during the Obama administration appears set to be put into practice, allowing more than one supplier of cannabis research products.
A Better Hydrogel for 3D Cell Culture
A Better Hydrogel for 3D Cell Culture
The Scientist Creative Services Team in collaboration with MilliporeSigma | May 13, 2021
Drug screening in 3D cell cultures is possible with the right tools.
Gene Therapy Continues to Benefit Kids with Immunodeficiency
Gene Therapy Continues to Benefit Kids with Immunodeficiency
Jef Akst | May 12, 2021
Four dozen children with severe combined immunodeficiency (SCID) who received a corrective gene carried by a virus have working immune systems two to three years later, according to three independent clinical trials.
Identifying Antibodies that Target Membrane Proteins in Their Native Conformations
Identifying Antibodies that Target Membrane Proteins in Their Native Conformations
The Scientist Creative Services Team in collaboration with OXGENE | May 10, 2021
A new mammalian display platform enhances antibody discovery for challenging protein targets.
Bio-Rad Launches Its Reliance SARS-CoV-2 RT-PCR Assay Kit in Europe
Bio-Rad Launches Its Reliance SARS-CoV-2 RT-PCR Assay Kit in Europe
Bio-Rad | May 10, 2021
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the Reliance SARS-CoV-2 RT-PCR Kit (IVD) for European markets after having met the CE-IVD mark requirements.  
Biden Administration Backs Vaccine Intellectual Property Waiver
Biden Administration Backs Vaccine Intellectual Property Waiver
Amanda Heidt | May 10, 2021
The move, which is not supported by the pharmaceutical industry, would allow other countries to design and manufacture COVID-19 vaccines without fear of litigation.
June 11, 2021 - Technique Talk: Optimizing PCR Quality and Yield
June 11, 2021 - Technique Talk: Optimizing PCR Quality and Yield
The Scientist Creative Services Team in collaboration with Merck | May 6, 2021
In this workshop, explore the importance of sample quality and polymerase selection for PCR quality and yield. 
Technique Talk: High-Throughput Drug Screening Using 3D Cell Culture
Technique Talk: High-Throughput Drug Screening Using 3D Cell Culture
The Scientist Creative Services Team in collaboration with MilliporeSigma | May 5, 2021
In this workshop, learn how to use hydrogel 3D cell culture plates for streamlined 3D cell culture colony formation, imaging, metabolic read-out, and T cell-mediated tumor cell killing.
Brain’s Lymphatic System Tied to Alzheimer’s Symptoms in Mice
Brain’s Lymphatic System Tied to Alzheimer’s Symptoms in Mice
Amanda Heidt | May 4, 2021
A dysfunctional lymphatic system, described as a clogging of the brain’s sink, may explain why immunotherapies fail in some Alzheimer’s patients.
Pandemic Accelerates Trend Toward Remote Clinical Trials
Pandemic Accelerates Trend Toward Remote Clinical Trials
Jef Akst | May 1, 2021
Now more than ever before, recruiting patients for a research study doesn’t have to mean getting them to leave their homes.